The American Association for Cancer Research (AACR) announced the launch of an international initiative known as AACR Project Genomics, Evidence, Neoplasia, Information, Exchange (GENIE). The initial phase of the project, which is being conducted in partnership with seven global leaders in genomic sequencing for clinical utility, as well as two informatics partners, will aggregate project members’ clinical-grade sequencing data to improve patient treatment decisions and catalyze clinical and translational research.
The seven founding members of the consortium and phase 1 participants are:
- The Center for Personalized Cancer Treatment, Utrecht, Netherlands;
- Dana-Farber Cancer Institute, Boston;
- Institut Gustave Roussy, Villejuif, France;
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore;
- Memorial Sloan Kettering Cancer Center, New York;
- Princess Margaret Cancer Centre, Toronto; and
- Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
The two informatics partners are:
- Sage Bionetworks, Seattle; and
- cBioPortal, New York.
Information
- Show
- PublishedNovember 6, 2015 at 11:02 PM UTC
- Length51 min
- RatingClean